Skip to main content

Aleve PM FDA Approval History

FDA Approved: Yes (First approved January 16, 2014)
Brand name: Aleve PM
Generic name: diphenhydramine hydrochloride and naproxen sodium
Dosage form: Caplets
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Pain, Insomnia

Aleve PM (diphenhydramine hydrochloride and naproxen sodium) is an over-the-counter antihistamine and nonsteroidal anti-inflammatory drug (NSAID) combination for the relief of occasional sleeplessness associated with minor aches and pains.

Development timeline for Aleve PM

DateArticle
Jan 16, 2014Approval FDA Approves Aleve PM (diphenhydramine hydrochloride and naproxen sodium)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.